Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH
Gianluca Svegliati‐Baroni, Bárbara G. Patrício, Gessica Lioci, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5820-5820
Open Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Haleh Chehrehgosha, Masoudreza Sohrabi, Faramarz Ismail‐Beigi, et al.
Diabetes Therapy (2021) Vol. 12, Iss. 3, pp. 843-861
Open Access | Times Cited: 110
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73
GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeys
Shu-Chen Lu, Michelle Chen, Larissa Atangan, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 5, pp. 100263-100263
Open Access | Times Cited: 62
Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis
Kailin Yang, Junpeng Chen, Tianqing Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 47
Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
Gao-Xin Xu, Wei Song, Chao Yu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 27
Modelling host–microbiome interactions in organ-on-a-chip platforms
Yong Cheol Shin, Nam Than, So‐Youn Min, et al.
Nature Reviews Bioengineering (2023) Vol. 2, Iss. 2, pp. 175-191
Closed Access | Times Cited: 16
Newly discovered endocrine functions of the liver
Jane Rhyu, Run Yu
World Journal of Hepatology (2021) Vol. 13, Iss. 11, pp. 1611-1628
Open Access | Times Cited: 38
Research progress on the regulation of production traits by gastrointestinal microbiota in dairy cows
Lily Liu, Peifu Wu, Aiwei Guo, et al.
Frontiers in Veterinary Science (2023) Vol. 10
Open Access | Times Cited: 12
Demethylenetetrahydroberberine alleviates nonalcoholic fatty liver disease by inhibiting the NLRP3 inflammasome and oxidative stress in mice
Yuanqiang Zhang, Jing Wen, Dongqing Liu, et al.
Life Sciences (2021) Vol. 281, pp. 119778-119778
Closed Access | Times Cited: 27
Lactobacillus plantarum SHY130 isolated from yak yogurt attenuates hyperglycemia in C57BL/6J mice by regulating the enteroinsular axis
Guangqi Wang, Jiajia Song, Yechuan Huang, et al.
Food & Function (2021) Vol. 13, Iss. 2, pp. 675-687
Closed Access | Times Cited: 27
Visible Photoluminescent Zinc Oxide Nanorods for Label-Free Nonenzymatic Glucose Detection
Maria Morais, Ana C. Marques, Sofia Henriques Ferreira, et al.
ACS Applied Nano Materials (2022) Vol. 5, Iss. 3, pp. 4386-4396
Closed Access | Times Cited: 19
Lipid Metabolism in MASLD and MASH: from mechanism to the clinic
Fabrizia Carli, Giuseppe Della Pepa, Silvia Sabatini, et al.
JHEP Reports (2024) Vol. 6, Iss. 12, pp. 101185-101185
Open Access | Times Cited: 3
Liver SMN restoration rescues the Smn mouse model of spinal muscular atrophy
Emma R Sutton, Ariane Beauvais, Rebecca Yaworski, et al.
EBioMedicine (2024) Vol. 110, pp. 105444-105444
Open Access | Times Cited: 3
Effect of Mastiha supplementation on NAFLD: The MAST4HEALTH Randomised, Controlled Trial
Charalampia Amerikanou, Stavroula Kanoni, Andriana C. Kaliora, et al.
Molecular Nutrition & Food Research (2021) Vol. 65, Iss. 10
Open Access | Times Cited: 25
A Newly Developed Synbiotic Yogurt Prevents Diabetes by Improving the Microbiome–Intestine–Pancreas Axis
Brandi Miller, Rabina Mainali, Ravinder Nagpal, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1647-1647
Open Access | Times Cited: 23
Role of Intestinal Microbes in Chronic Liver Diseases
Mengyi Xu, Kangkang Luo, Junjie Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12661-12661
Open Access | Times Cited: 17
Nutritional and Lifestyle Therapy for NAFLD in People with HIV
Felice Cinque, Annalisa Cespiati, Rosa Lombardi, et al.
Nutrients (2023) Vol. 15, Iss. 8, pp. 1990-1990
Open Access | Times Cited: 10
Gut microbial dysbiosis is associated with metabolism and immune factors in liver fibrosis mice
Bing Zhao, Ye Jin, Meixin Shi, et al.
International Journal of Biological Macromolecules (2023) Vol. 258, pp. 129052-129052
Closed Access | Times Cited: 9
Omega‐3 phospholipids and obesity‐associated NAFLD: Potential mechanisms and therapeutic perspectives
Milena Mitrović, Gabriella Sistilli, Olga Horakova, et al.
European Journal of Clinical Investigation (2021) Vol. 52, Iss. 3
Open Access | Times Cited: 21
Flaxseed Powder Attenuates Non-Alcoholic Steatohepatitis via Modulation of Gut Microbiota and Bile Acid Metabolism through Gut–Liver Axis
Chao Yang, Min Wan, Dengfeng Xu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10858-10858
Open Access | Times Cited: 20
GLP-1 mimetics as a potential therapy for nonalcoholic steatohepatitis
Yan Chen, Ying-na Xu, Chen-yu Ye, et al.
Acta Pharmacologica Sinica (2021) Vol. 43, Iss. 5, pp. 1156-1166
Open Access | Times Cited: 20
Platelets in Non-alcoholic Fatty Liver Disease
Andrea Dalbeni, Marco Castelli, Mirko Zoncapè, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Metabolic traits affecting the relationship between liver fat and intrapancreatic fat: a mediation analysis
Juyeon Ko, Ivana R. Sequeira, Loren Skudder‐Hill, et al.
Diabetologia (2022) Vol. 66, Iss. 1, pp. 190-200
Open Access | Times Cited: 15
Marked gut microbiota dysbiosis and increased imidazole propionate are associated with a NASH Göttingen Minipig model
Ditte Olsen Lützhøft, Tim Sinioja, Berit Østergaard Christoffersen, et al.
BMC Microbiology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Comparison of Animal Models for the Study of Nonalcoholic Fatty Liver Disease
Qing Zheng, Min Zhu, Xin Zeng, et al.
Laboratory Investigation (2023) Vol. 103, Iss. 7, pp. 100129-100129
Closed Access | Times Cited: 7
Page 1 - Next Page

Scroll to top